This follows a previous article with a general summary of the two medication studies for BPD presented here: http://pdan.org/drug-trials-encouraging-results-for-bpd/ SEROQUEL XR (OLANZAPINE) STUDY FOR BPD, 2010-2013 “Comparison of Low and Moderate Dosages of Extended- Release Quetiapine in Borderline Personality Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial”, by Donald Black, Mary Zanarini, Ann […]
Read more →Borderline Personality Disorder (BPD) is a mental disorder that develops slowly, usually in adolescence and young adults and resolves slowly. After 4 years about 50 percent of BPD sufferers will remit, and after 10 years nearly 85 percent. When treated with empirically-validated treatments, these figures are considerably […]
Read more →The following is an excerpt of advice from Mark S. Komrad M.D., author of: “You Need Help: A Step-by-Step Plan to Convince a Loved One to Get Counseling.” The situation is one where a parent came to Dr. Komrad for advice on his child who is in therapy. In […]
Read more →Forward by Frederic Bien; President of PDAN Several personality disorders are connected to depression, or have overlaps with it, during the lifetime of an individual. There can be a strong sense of isolation or inadequacy felt by people suffering from ailments, such as avoidant, paranoid, schizoid […]
Read more →
“It’s not so easy to just move forward if you are held by back by psychological symptoms you don’t understand”… (From a comment on PDAN’s Facebook Page) I am one of several administrators for a wonderful Facebook Page called PDAN, which stands for “Personality Disorders Awareness Network” […]
Read more →
RECENT COMMENTS